Vimarsana
Biggest News Aggregation in the World

Stephen Stahl News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stephen Stahl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stephen Stahl Today - Breaking & Trending Today

An Artisanal Approach to Care: A Conversation with Joseph F. Goldberg, MD - Vimarsana News

An Artisanal Approach to Care: A Conversation with Joseph F. Goldberg, MD

Joseph F. Goldberg, MD, sat down with Psychiatric Times' Editor-in-Chief at the 2024 APA Annual Meeting.

Iloperidone (Fanapt) for Bipolar 1 Disorder Treatment Gets FDA Okay - Vimarsana News

Iloperidone (Fanapt) for Bipolar 1 Disorder Treatment Gets FDA Okay

Already approved for schizophrenia, this antipsychotic medication is now approved for adults with bipolar 1 disorder.

FDA Approves Iloperidone for Adults with Bipolar 1 Disorder - Vimarsana News

FDA Approves Iloperidone for Adults with Bipolar 1 Disorder

Vanda Pharmaceuticals announces the FDA approval of iloperidone (Fanapt) for the acute treatment of bipolar 1 disorder.

Source: ajmc.com
FDA Approves Fanapt for Mixed, Manic Episodes Associated With Bipolar I Disorder - Vimarsana News

FDA Approves Fanapt for Mixed, Manic Episodes Associated With Bipolar I Disorder

The atypical antipsychotic was approved for the acute treatment of schizophrenia in 2009.

Putting JAMA Psychiatry and MIA to the Genetic Test - Vimarsana News

Putting JAMA Psychiatry and MIA to the Genetic Test

We can assess whether Mad in America readers or JAMA Psychiatry readers are being provided with the most robust scientific literature.